Olorigliflozin, also known as rongliflozin, is an investigational new drug that is being evaluated by HEC Pharm for the treatment of type 2 diabetes mellitus. It is a sodium-glucose transporter 2 inhibitor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.